This HTML5 document contains 34 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n9http://linked.opendata.cz/resource/drugbank/drug/DB07494/identifier/pubchem-compound/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n10http://linked.opendata.cz/resource/drugbank/drug/DB07494/identifier/pubchem-substance/
n11http://linked.opendata.cz/resource/drugbank/drug/DB07494/identifier/drugbank/
n6http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n13http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n12http://linked.opendata.cz/resource/drugbank/drug/DB07494/identifier/pdb/

Statements

Subject Item
n2:DB07494
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB07494 n13:DB07494
dcterms:title
(3-EXO)-3-(10,11-DIHYDRO-5H-DIBENZO[A,D][7]ANNULEN-5-YLOXY)-8,8-DIMETHYL-8-AZONIABICYCLO[3.2.1]OCTANE
adms:identifier
n9:21124461 n10:99443965 n11:DB07494 n12:BS1
n3:IUPAC-Name
n4:271B49D6-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B49DC-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B49DB-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B49D8-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B49D9-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B49DA-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B49D4-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B49D2-363D-11E5-9242-09173F13E4C5 n4:271B49D5-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B49D3-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B49E2-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B49E3-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B49DD-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B49DE-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B49E0-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B49DF-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B49E1-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B49E7-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B49E9-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B49EA-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B49E6-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B49E5-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B49E8-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B49D7-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B49E4-363D-11E5-9242-09173F13E4C5